← back to search

Marc Lütgehetmann

Universität Hamburg · DE
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis B Virus Studies, Hepatitis C virus research, SARS-CoV-2 and COVID-19 Research, and Hepatitis Viruses Studies and Epidemiology.
h-index
58
citations
16,624
works
458
NIH funding
primary concept
Medicine
email

Recent publications

Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Nature Communications 2026cited by 1position: middledoi
Fatal Cerebral Venous Sinus Thrombosis and Thrombocytopenia due to Anti-PF4 Disorder Following Adenovirus Infection in a 3-year-old Boy
Thrombosis and Haemostasis 2025cited by 2position: middledoi
Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional study
BMC Women s Health 2025cited by 1position: middledoi
Performance of Elecsys Anti‐ <scp>HEV IgG</scp> and <scp>IgM</scp> Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection
Liver International 2025cited by 0position: lastdoi
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies
Journal of Hepatology 2024cited by 42position: middledoi
Inefficient tissue immune response against MPXV in an immunocompromised mpox patient
Journal of Medical Virology 2024cited by 5position: middledoi
Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany — A nationwide multi-center cross-sectional study
Frontiers in Public Health 2024cited by 3position: middledoi
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
Gut 2023cited by 73position: middledoi
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
Journal of Hepatology 2023cited by 49position: middledoi
HDV RNA assays: Performance characteristics, clinical utility, and challenges
Hepatology 2023cited by 47position: middledoi
Molecular consequences of SARS-CoV-2 liver tropism
Nature Metabolism 2022cited by 158position: middledoi
First report from the German COVID-19 autopsy registry
The Lancet Regional Health - Europe 2022cited by 65position: middledoi
Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure: a nationwide register study report
Critical Care 2022cited by 25position: middledoi
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme
European Heart Journal 2021cited by 175position: middledoi
Clonal expansion and activation of tissue-resident memory-like T <sub>H</sub> 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19
Science Immunology 2021cited by 172position: middledoi
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
PLoS Pathogens 2021cited by 50position: middledoi
Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma
Journal of Hepatology 2021cited by 36position: middledoi
KIR3DS1 directs NK cell–mediated protection against human adenovirus infections
Science Immunology 2021cited by 17position: middledoi
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Annals of Internal Medicine 2020cited by 2,383position: middledoi
Multiorgan and Renal Tropism of SARS-CoV-2
New England Journal of Medicine 2020cited by 1,869position: middledoi
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
The Lancet Neurology 2020cited by 1,348position: middledoi
Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study
Viruses 2019cited by 43position: middledoi
Hepatitis E seroprevalence in the Americas: A systematic review and meta‐analysis
Liver International 2018cited by 61position: middledoi
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection
Science Translational Medicine 2018cited by 44position: middledoi
Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants
Journal of Clinical Microbiology 2018cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Heiner Wedemeyer · Ruhr University Bochum5 papers (2018–2024)Lena Allweiss · Universität Hamburg4 papers (2020–2024)Susanne Pfefferle · Universität Hamburg4 papers (2020–2024)Markus Glatzel · Universität Hamburg4 papers (2020–2025)Maura Dandri · Chulalongkorn University3 papers (2020–2024)Jakob Matschke · Universität Hamburg3 papers (2020–2025)Sven Pischke · Medizinische Hochschule Hannover3 papers (2018–2019)Susanne Krasemann · University Medical Center Hamburg-Eppendorf2 papers (2020–2024)Benjamin Ondruschka · New South Wales Department of Health2 papers (2024–2025)Klaus Püschel · Universität Hamburg2 papers (2020–2024)Carolin Edler · Universität Hamburg2 papers (2020–2020)Martin Aepfelbacher · Universität Hamburg2 papers (2020–2020)Ansgar W. Lohse · Universität Hamburg2 papers (2018–2019)Jürgen J. Wenzel · Institute of Medical Microbiology and Hygiene2 papers (2021–2025)Stephan Urban · University Hospital Münster2 papers (2023–2024)Ann Sophie Schröder · University of the Faroe Islands2 papers (2020–2020)Axel Heinemann · Universität Hamburg2 papers (2020–2020)Jan Sperhake · Universität Hamburg2 papers (2020–2020) · 1 papers (2025–2025) · 1 papers (2026–2026)